P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

• Ajai Chari,
• Joris Diels,
• Suzy Van Sanden,
• Lixia Pei,
• Eric Ammann,
• Christoph Heuck,
• Colleen Kane,
• Anil Londhe,
• Steve Peterson,
• Donna Reece

Affiliations

Ajai Chari

1 Mount Sinai School of Medicine, New York, United States

Joris Diels

2 Janssen Pharmaceutica NV, Beerse, Belgium

Suzy Van Sanden

2 Janssen Pharmaceutica NV, Beerse, Belgium

Lixia Pei

3 Janssen Research & Development, Raritan, United States

Eric Ammann

4 Janssen Global Services, Raritan, United States

Christoph Heuck

5 Janssen Research & Development, Spring House, United States

Colleen Kane

5 Janssen Research & Development, Spring House, United States

Anil Londhe

6 Janssen Research & Development, Titusville, United States

Steve Peterson

7 Janssen Research & Development, Horsham, United States

Donna Reece

8 Princess Margaret Cancer Centre, Toronto, Canada